Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz 3D ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of Viz 3D CTA, a new solution that automatically converts computed tomography ...

The investigational device exemption trial enrolled 130 acute intermediate-risk pulmonary embolism patients across 22 US ...

today announced the launch of Viz 3D CTA, a new solution that automatically converts computed tomography angiography (CTA) scans into high-resolution, AI-enhanced 3D images for faster and clearer ...

In addition, the use of 64-slice computed tomography angiography (CTA) has resulted in incremental increases in volume coverage, spatial and temporal resolution, as well as a reduction in ...

Patients aged 18 to 80 years of age with symptomatic computed tomography angiography (CTA)-documented acute intermediate-risk PE of ≤14 days duration were eligible for enrollment. Intermediate ...

YCharts, a leading investment research and proposal generation platform, is expanding its presence in the Canadian wealth management market with a new integration with Aviso Wealth, a leading Canadian ...